B C Schultes

Author PubWeight™ 4.15^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.	Cancer Biother Radiopharm	2001	0.94
2	Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity.	Ann Oncol	2004	0.87
3	A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer.	Int J Gynecol Cancer	2005	0.85
4	Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997.	Tumour Biol	1998	0.79
5	OVAREX MAb-B43.13:IFN-gamma could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cells.	Hybridoma	1997	0.75
6	Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine.	Hybrid Hybridomics	2001	0.75